agilon health (NYSE:AGL) Downgraded to Market Perform Rating by William Blair

agilon health (NYSE:AGL - Get Free Report) was downgraded by research analysts at William Blair from an "outperform" rating to a "market perform" rating in a note issued to investors on Friday, Marketbeat reports.

Other analysts have also issued research reports about the stock. Benchmark reaffirmed a "buy" rating and set a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft reduced their target price on agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a research report on Friday, August 9th. Bank of America cut agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target for the company. in a report on Wednesday, October 2nd. Citigroup restated a "sell" rating and issued a $2.50 price objective (down from $7.00) on shares of agilon health in a report on Tuesday, October 29th. Finally, Evercore ISI lowered their target price on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a research note on Tuesday, October 8th. Three investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $7.81.

agilon health Trading Down 34.1 %

NYSE:AGL traded down $0.95 during trading hours on Friday, hitting $1.84. The company had a trading volume of 19,063,455 shares, compared to its average volume of 4,945,005. agilon health has a 1 year low of $1.80 and a 1 year high of $13.76. The company has a market cap of $757.12 million, a P/E ratio of -2.70 and a beta of 0.60. The company has a 50-day moving average of $3.31 and a 200 day moving average of $5.00. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. agilon health's revenue was up 38.7% compared to the same quarter last year. During the same period last year, the business earned ($0.04) earnings per share. Sell-side analysts expect that agilon health will post -0.32 earnings per share for the current year.

Insider Activity at agilon health

In related news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction dated Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 3.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On agilon health

A number of hedge funds and other institutional investors have recently modified their holdings of the company. J.Safra Asset Management Corp boosted its holdings in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after purchasing an additional 3,625 shares in the last quarter. CWM LLC grew its position in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after buying an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC acquired a new stake in agilon health during the 2nd quarter worth $60,000. Bleakley Financial Group LLC purchased a new stake in agilon health in the first quarter valued at $65,000. Finally, Allspring Global Investments Holdings LLC boosted its stake in agilon health by 17,790.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company's stock valued at $70,000 after acquiring an additional 10,674 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.